MDT logo

Medtronic plc (MDT) Cash and cash equivalents

annual cash & cash equivalents:

$8.96B+$960.00M(+11.99%)
April 25, 2025

Summary

  • As of today (August 16, 2025), MDT annual cash & cash equivalents is $8.96 billion, with the most recent change of +$960.00 million (+11.99%) on April 25, 2025.
  • During the last 3 years, MDT annual cash & cash equivalents has fallen by -$1.61 billion (-15.21%).
  • MDT annual cash & cash equivalents is now -53.98% below its all-time high of $19.48 billion, reached on April 24, 2015.

Performance

1-year change

+11.99%

3-year change

-15.21%

5-year change

-18.11%

15-year change

-20.15%

MDT Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

99.02%
MDT annual cash & cash equivalents is higher than 99.02% of companies in Healthcare sector

Range

All-time high

$19.48B
MDT annual cash & cash equivalents is currently -53.98% below its historical high of $19.48 billion

3-year low

$7.96B
MDT annual cash & cash equivalents is currently +12.64% above its 3-year low

Earnings dates

Last annual earnings report date

Apr 25, 2025
MDT previous annual earnings announcement was published on Apr 25, 2025

Next annual earnings report date

N/A
MDT next annual earnings announcement has not yet been scheduled

OtherMDTbalance sheet metrics

quarterly total assets

$91.68B
MDT quarterly total assets is $91.68 billion

quarterly current assets

$23.81B
MDT quarterly total current assets is $23.81 billion

quarterly total liabilities

$43.42B
MDT quarterly total liabilities is $43.42 billion

quarterly current liabilities

$12.88B
MDT quarterly total current liabilities is $12.88 billion

quarterly cash & cash equivalents:

$2.22B+$978.00M(+78.87%)
April 25, 2025

Summary

  • As of today (August 16, 2025), MDT quarterly cash & cash equivalents is $2.22 billion, with the most recent change of +$978.00 million (+78.87%) on April 25, 2025.
  • Over the past year, MDT quarterly cash & cash equivalents has increased by +$934.00 million (+72.74%).
  • MDT quarterly cash & cash equivalents is now -87.13% below its all-time high of $17.23 billion, reached on January 31, 2015.

Performance

3-month change

+78.87%

1-year change

+72.74%

3-year change

-40.28%

5-year change

-46.43%

MDT quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

96.8%
MDT quarterly cash & cash equivalents is higher than 96.8% of companies in Healthcare sector

Range

All-time high

$17.23B
MDT quarterly cash & cash equivalents is currently -87.13% below its historical high of $17.23 billion

3-year low

$1.24B
MDT quarterly cash & cash equivalents is currently +78.87% above its 3-year low

Earnings dates

Last quarterly earnings report date

Apr 25, 2025
MDT previous earnings announcement was published on Apr 25, 2025

Next quarterly earnings report date

Aug 19, 2025
MDT next earnings announcement is scheduled for Aug 19, 2025

OtherMDTbalance sheet metrics

quarterly total assets

$91.68B
MDT quarterly total assets is $91.68 billion

quarterly current assets

$23.81B
MDT quarterly total current assets is $23.81 billion

quarterly total liabilities

$43.42B
MDT quarterly total liabilities is $43.42 billion

quarterly current liabilities

$12.88B
MDT quarterly total current liabilities is $12.88 billion

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

MDT Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+12.0%+72.7%
3 y3 years-15.2%-40.3%
5 y5 years-18.1%-46.4%

MDT Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-15.2%+12.6%-54.1%+78.9%
5 y5-year-18.1%+12.6%-65.9%+78.9%
alltimeall time-54.0%>+9999.0%-87.1%+8916.3%

MDT Cash and cash equivalents History

DateAnnualQuarterly
Apr 2025
$8.96B(+12.0%)
$2.22B(+78.9%)
Jan 2025
-
$1.24B(-11.0%)
Oct 2024
-
$1.39B(+6.3%)
Jul 2024
-
$1.31B(+2.1%)
Apr 2024
-
$1.28B(-20.9%)
Apr 2024
$8.01B(+0.6%)
-
Jan 2024
-
$1.62B(+23.8%)
Oct 2023
-
$1.31B(-2.1%)
Jul 2023
-
$1.34B(-13.2%)
Apr 2023
-
$1.54B(-65.9%)
Apr 2023
$7.96B(-24.7%)
-
Jan 2023
-
$4.52B(-6.4%)
Oct 2022
-
$4.83B(+125.6%)
Jul 2022
-
$2.14B(-42.4%)
Apr 2022
$10.57B(-2.3%)
$3.71B(+6.8%)
Jan 2022
-
$3.48B(+20.0%)
Oct 2021
-
$2.90B(-3.5%)
Jul 2021
-
$3.00B(-16.4%)
Apr 2021
$10.82B(-1.2%)
$3.59B(-29.2%)
Jan 2021
-
$5.08B(-20.9%)
Oct 2020
-
$6.42B(-1.2%)
Jul 2020
-
$6.50B(+57.0%)
Apr 2020
$10.95B(+11.2%)
$4.14B(+11.6%)
Jan 2020
-
$3.71B(-6.4%)
Oct 2019
-
$3.96B(-22.0%)
Jul 2019
-
$5.08B(+15.6%)
Apr 2019
$9.85B(-12.3%)
$4.39B(+18.6%)
Jan 2019
-
$3.70B(-5.3%)
Oct 2018
-
$3.91B(-10.7%)
Jul 2018
-
$4.38B(+19.4%)
Apr 2018
$11.23B(-18.1%)
$3.67B(-42.3%)
Jan 2018
-
$6.36B(+15.0%)
Oct 2017
-
$5.53B(+17.9%)
Jul 2017
-
$4.69B(-5.6%)
Apr 2017
$13.71B(+8.5%)
$4.97B(+79.4%)
Jan 2017
-
$2.77B(-6.3%)
Oct 2016
-
$2.95B(-3.5%)
Jul 2016
-
$3.06B(+6.4%)
Apr 2016
$12.63B(-35.1%)
$2.88B(+5.7%)
Jan 2016
-
$2.72B(+14.4%)
Oct 2015
-
$2.38B(-20.2%)
Jul 2015
-
$2.98B(-38.5%)
Apr 2015
$19.48B(+36.8%)
$4.84B(-71.9%)
Jan 2015
-
$17.23B(+1238.9%)
Oct 2014
-
$1.29B(-3.7%)
Jul 2014
-
$1.34B(-4.8%)
Apr 2014
$14.24B(+28.6%)
$1.40B(+7.6%)
Jan 2014
-
$1.30B(+22.3%)
Oct 2013
-
$1.07B(+28.7%)
Jul 2013
-
$828.00M(-9.9%)
Apr 2013
$11.07B(+327.1%)
$919.00M(-29.2%)
Jan 2013
-
$1.30B(-26.2%)
Oct 2012
-
$1.76B(+104.3%)
Jul 2012
-
$861.00M(-26.5%)
Apr 2012
$2.59B(+6.8%)
$1.17B(-1.5%)
Jan 2012
-
$1.19B(+13.5%)
Oct 2011
-
$1.05B(-24.8%)
Jul 2011
-
$1.39B(+0.8%)
Apr 2011
$2.43B(-35.7%)
$1.38B(+7.7%)
Jan 2011
-
$1.28B(+2.1%)
Oct 2010
-
$1.26B(-7.9%)
Jul 2010
-
$1.36B(-2.6%)
Apr 2010
$3.77B(+125.2%)
$1.40B(-4.3%)
Jan 2010
-
$1.46B(+77.1%)
Oct 2009
-
$826.00M(-19.2%)
Jul 2009
-
$1.02B(-19.6%)
Apr 2009
$1.68B(+3.9%)
$1.27B(-0.9%)
Jan 2009
-
$1.28B(+137.2%)
Oct 2008
-
$541.00M(-53.8%)
Jul 2008
-
$1.17B(+10.4%)
Apr 2008
$1.61B(-47.6%)
$1.06B(+45.4%)
Jan 2008
-
$729.00M(-84.4%)
Oct 2007
-
$4.68B(+436.4%)
Jul 2007
-
$873.00M(-30.5%)
Apr 2007
$3.08B
$1.26B(-39.8%)
Jan 2007
-
$2.09B(+91.5%)
DateAnnualQuarterly
Oct 2006
-
$1.09B(-21.9%)
Jul 2006
-
$1.40B(-53.4%)
Apr 2006
$6.10B(+79.9%)
$2.99B(+118.9%)
Jan 2006
-
$1.37B(-29.8%)
Oct 2005
-
$1.95B(+22.5%)
Jul 2005
-
$1.59B(-28.8%)
Apr 2005
$3.39B(+76.0%)
$2.23B(+2.1%)
Jan 2005
-
$2.19B(-4.9%)
Oct 2004
-
$2.30B(+6.8%)
Jul 2004
-
$2.15B(+35.0%)
Apr 2004
$1.93B(+29.1%)
$1.59B(+25.7%)
Jan 2004
-
$1.27B(+30.5%)
Oct 2003
-
$971.00M(-17.2%)
Jul 2003
-
$1.17B(-20.2%)
Apr 2003
$1.49B(+179.7%)
$1.47B(+0.1%)
Jan 2003
-
$1.47B(+48.2%)
Oct 2002
-
$990.90M(+13.6%)
Jul 2002
-
$872.10M(+112.3%)
Apr 2002
$533.70M(-4.4%)
$410.70M(-10.5%)
Jan 2002
-
$458.80M(+62.1%)
Oct 2001
-
$283.10M(-75.8%)
Jul 2001
-
$1.17B(+13.6%)
Apr 2001
-
$1.03B(+129.6%)
Jan 2001
-
$448.80M(-23.6%)
Oct 2000
-
$587.50M(+2.1%)
Jul 2000
-
$575.20M(+23.0%)
Apr 2000
$558.10M(+48.5%)
$467.80M(+202.2%)
Jan 2000
-
$154.80M(-1.9%)
Oct 1999
-
$157.80M(-31.4%)
Jul 1999
-
$230.00M(+0.7%)
Apr 1999
$375.90M(+420.3%)
$228.50M(-34.1%)
Jan 1999
-
$346.60M(-39.4%)
Oct 1998
-
$572.30M(+120.8%)
Jul 1998
-
$259.20M(-50.1%)
Apr 1998
-
$519.50M(+67.3%)
Jan 1998
-
$310.60M(+4.3%)
Oct 1997
-
$297.90M(+6.3%)
Jul 1997
-
$280.20M(+41.9%)
Apr 1997
-
$197.40M(+223.1%)
Jan 1997
-
$61.10M(-31.3%)
Oct 1996
-
$89.00M(-26.5%)
Jul 1996
-
$121.10M(+9.8%)
Apr 1996
-
$110.30M(-8.2%)
Jan 1996
-
$120.10M(-3.4%)
Oct 1995
-
$124.30M(-12.2%)
Jul 1995
-
$141.60M(+44.0%)
Apr 1995
-
$98.30M(-24.0%)
Jan 1995
-
$129.30M(+12.4%)
Oct 1994
-
$115.00M(+49.4%)
Jul 1994
-
$77.00M(-29.2%)
Apr 1994
-
$108.70M(-8.7%)
Jan 1994
-
$119.00M(+104.8%)
Oct 1993
-
$58.10M(-14.3%)
Jul 1993
-
$67.80M(-11.9%)
Apr 1993
-
$77.00M(-46.3%)
Jan 1993
-
$143.50M(+6.1%)
Oct 1992
-
$135.20M(+102.4%)
Jul 1992
-
$66.80M(-33.7%)
Apr 1992
-
$100.80M(+18.4%)
Jan 1992
-
$85.10M(+28.7%)
Oct 1991
-
$66.10M(-0.8%)
Jul 1991
-
$66.60M(-25.0%)
Apr 1991
-
$88.80M(+24.5%)
Jan 1991
-
$71.30M(+23.6%)
Oct 1990
-
$57.70M(+3.2%)
Jul 1990
-
$55.90M(+54.4%)
Apr 1990
-
$36.20M(+47.2%)
Jan 1990
-
$24.60M(-15.8%)
Oct 1989
-
$29.20M(-43.1%)
Apr 1989
-
$51.30M(-34.6%)
Apr 1988
-
$78.50M(-31.0%)
Apr 1987
-
$113.70M(-16.0%)
Apr 1986
-
$135.40M(-1.2%)
Apr 1985
-
$137.10M(+17.7%)
Apr 1984
-
$116.50M
Apr 1982
$72.25M(+24.6%)
-
Apr 1981
$57.98M
-

FAQ

  • What is Medtronic plc annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Medtronic plc?
  • What is Medtronic plc annual cash & cash equivalents year-on-year change?
  • What is Medtronic plc quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Medtronic plc?
  • What is Medtronic plc quarterly cash & cash equivalents year-on-year change?

What is Medtronic plc annual cash & cash equivalents?

The current annual cash & cash equivalents of MDT is $8.96B

What is the all time high annual cash & cash equivalents for Medtronic plc?

Medtronic plc all-time high annual cash & cash equivalents is $19.48B

What is Medtronic plc annual cash & cash equivalents year-on-year change?

Over the past year, MDT annual cash & cash equivalents has changed by +$960.00M (+11.99%)

What is Medtronic plc quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of MDT is $2.22B

What is the all time high quarterly cash & cash equivalents for Medtronic plc?

Medtronic plc all-time high quarterly cash & cash equivalents is $17.23B

What is Medtronic plc quarterly cash & cash equivalents year-on-year change?

Over the past year, MDT quarterly cash & cash equivalents has changed by +$934.00M (+72.74%)
On this page